Literature DB >> 20447849

In silico classification of adenosine receptor antagonists using Laplacian-modified naïve Bayesian, support vector machine, and recursive partitioning.

Jin Hee Lee1, Sunkyung Lee, Sun Choi.   

Abstract

Adenosine receptors (ARs) belong to the G-protein-coupled receptor (GPCR) superfamily and consist of four subtypes referred to as A(1), A(2A), A(2B), and A(3). It is important to develop potent and selective modulators of ARs for therapeutic applications. In order to develop reliable in silico models that can effectively classify antagonists of each AR, we carried out three machine learning methods: Laplacian-modified naïve Bayesian, recursive partitioning, and support vector machine. The results for each classification model showed values high in accuracy, sensitivity, specificity, area under the receiver operating characteristic curve and Matthews correlation coefficient. By highlighting representative antagonists, the models demonstrated their power and usefulness, and these models could be utilized to predict potential AR antagonists in drug discovery. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Mesh:

Substances:

Year:  2010        PMID: 20447849     DOI: 10.1016/j.jmgm.2010.03.008

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  3 in total

1.  Fragment virtual screening based on Bayesian categorization for discovering novel VEGFR-2 scaffolds.

Authors:  Yanmin Zhang; Yu Jiao; Xiao Xiong; Haichun Liu; Ting Ran; Jinxing Xu; Shuai Lu; Anyang Xu; Jing Pan; Xin Qiao; Zhihao Shi; Tao Lu; Yadong Chen
Journal:  Mol Divers       Date:  2015-05-29       Impact factor: 2.943

2.  Robust optimization of SVM hyperparameters in the classification of bioactive compounds.

Authors:  Wojciech M Czarnecki; Sabina Podlewska; Andrzej J Bojarski
Journal:  J Cheminform       Date:  2015-08-14       Impact factor: 5.514

Review 3.  Exploring G Protein-Coupled Receptors (GPCRs) Ligand Space via Cheminformatics Approaches: Impact on Rational Drug Design.

Authors:  Shaherin Basith; Minghua Cui; Stephani J Y Macalino; Jongmi Park; Nina A B Clavio; Soosung Kang; Sun Choi
Journal:  Front Pharmacol       Date:  2018-03-09       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.